REC4 (ECOG-ACRIN EA8143)

 
 
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Clinical Trials Committee Approval: : March 21, 2017
Projected Activation: Summer 2018
Study Chair Dr. Anil Kapoor
Dr. Daniel Heng
Email: kapoor4@mcmaster.ca
Email: daniel.heng@albertahealthservices.ca
Senior Investigator Dr. Francisco Vera-Badillo Email: fverabadillo@ctg.queensu.ca
Study Coordinator Paul Stos Email: pstos@ctg.queensu.ca